A Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid Tumours

NCT02977364 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma
Solid Tumor, Adult

Interventions

DRUG: HS-10241

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.